Literature DB >> 23341225

Chronic inflammatory muscle diseases and risk of coronary artery disease.

Betul M Gundogdu1, Mehmet Cilingiroglu.   

Abstract

Despite recent advancements in the treatment of coronary artery disease (CAD), it remains the commonest cause of death in the world. Although traditional risk factors partially account for the development of CAD, other novel risk factors have recently been implicated. Specifically, chronic inflammation has been postulated to play a role in the development and propagation of this disease. The purpose of this review is to examine the available evidence to determine if patients with chronic inflammatory muscle diseases have higher rates of cardiovascular disease.

Entities:  

Mesh:

Year:  2013        PMID: 23341225     DOI: 10.1007/s11883-012-0308-2

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  34 in total

Review 1.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

Authors:  Thomas A Pearson; Steven N Blair; Stephen R Daniels; Robert H Eckel; Joan M Fair; Stephen P Fortmann; Barry A Franklin; Larry B Goldstein; Philip Greenland; Scott M Grundy; Yuling Hong; Nancy Houston Miller; Ronald M Lauer; Ira S Ockene; Ralph L Sacco; James F Sallis; Sidney C Smith; Neil J Stone; Kathryn A Taubert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

Review 2.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

3.  Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.

Authors:  C Heeschen; C W Hamm; J Bruemmer; M L Simoons
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

4.  No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.

Authors:  A Trion; M P M de Maat; J W Jukema; A van der Laarse; M C Maas; E H Offerman; L M Havekes; A J Szalai; H M G Princen; J J Emeis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-05-26       Impact factor: 8.311

5.  Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.

Authors:  James S Zebrack; Jeffrey L Anderson; Chloe Allen Maycock; Benjamin D Horne; Tami L Bair; Joseph Brent Muhlestein
Journal:  Am J Cardiol       Date:  2002-01-15       Impact factor: 2.778

6.  Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.

Authors:  Christopher Heeschen; Stefanie Dimmeler; Christian W Hamm; Stephan Fichtlscherer; Eric Boersma; Maarten L Simoons; Andreas M Zeiher
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

Review 7.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

8.  Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies.

Authors:  Jens Schmidt; Marinos C Dalakas
Journal:  Expert Opin Med Diagn       Date:  2010-03-29

9.  No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.

Authors:  Michael Torzewski; Kurt Reifenberg; Fei Cheng; Elena Wiese; Ines Küpper; Jeanine Crain; Karl J Lackner; Sucharit Bhakdi
Journal:  Thromb Haemost       Date:  2008-01       Impact factor: 5.249

Review 10.  C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.

Authors:  David I Buckley; Rongwei Fu; Michele Freeman; Kevin Rogers; Mark Helfand
Journal:  Ann Intern Med       Date:  2009-10-06       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.